Lisa A. Carey, MD, FASCO
Lisa A. Carey, MD, FASCO
Verified email at med.unc.edu
Title
Cited by
Cited by
Year
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
LA Carey, CM Perou, CA Livasy, LG Dressler, D Cowan, K Conway, ...
Jama 295 (21), 2492-2502, 2006
41582006
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes
LA Carey, EC Dees, L Sawyer, L Gatti, DT Moore, F Collichio, DW Ollila, ...
Clinical cancer research 13 (8), 2329-2334, 2007
22942007
The molecular portraits of breast tumors are conserved across microarray platforms
Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ...
BMC genomics 7 (1), 1-12, 2006
16152006
Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
JD Brenton, LA Carey, AA Ahmed, C Caldas
Journal of clinical oncology 23 (29), 7350-7360, 2005
11042005
Epidemiology of basal-like breast cancer
RC Millikan, B Newman, CK Tse, PG Moorman, K Conway, LV Smith, ...
Breast cancer research and treatment 109 (1), 123-139, 2008
10312008
Triple-negative breast cancer: disease entity or title of convenience?
L Carey, E Winer, G Viale, D Cameron, L Gianni
Nature reviews Clinical oncology 7 (12), 683-692, 2010
7522010
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
6662017
Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals
A Flanagin, LA Carey, PB Fontanarosa, SG Phillips, BP Pace, ...
Jama 280 (3), 222-224, 1998
6661998
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete …
WM Sikov, DA Berry, CM Perou, B Singh, CT Cirrincione, SM Tolaney, ...
Journal of clinical oncology 33 (1), 13, 2015
6642015
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
6512018
Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer
CK Anders, LA Carey
Clinical breast cancer 9, S73-S81, 2009
6362009
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
5752017
Phase II trial of bicalutamide in patients with androgen receptor–positive, estrogen receptor–negative metastatic breast cancer
A Gucalp, S Tolaney, SJ Isakoff, JN Ingle, MC Liu, LA Carey, K Blackwell, ...
Clinical cancer research 19 (19), 5505-5512, 2013
5442013
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
SM Tolaney, WT Barry, CT Dang, DA Yardley, B Moy, PK Marcom, ...
New England Journal of Medicine 372 (2), 134-141, 2015
5222015
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer
A Prat, B Adamo, MCU Cheang, CK Anders, LA Carey, CM Perou
The oncologist 18 (2), 123, 2013
5002013
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2–positive breast cancer
NU Lin, LA Carey, MC Liu, J Younger, SE Come, M Ewend, GJ Harris, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
4732008
Triple-negative breast cancer: risk factors to potential targets
BP Schneider, EP Winer, WD Foulkes, J Garber, CM Perou, A Richardson, ...
Clinical Cancer Research 14 (24), 8010-8018, 2008
4652008
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer
LA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ...
Journal of clinical oncology 30 (21), 2615, 2012
4622012
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer
M Kaufmann, G Von Minckwitz, EP Mamounas, D Cameron, LA Carey, ...
Annals of surgical oncology 19 (5), 1508-1516, 2012
4272012
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study
KM O'Brien, SR Cole, CK Tse, CM Perou, LA Carey, WD Foulkes, ...
Clinical Cancer Research 16 (24), 6100-6110, 2010
4062010
The system can't perform the operation now. Try again later.
Articles 1–20